Pharmaceutical products

Tender description

Invitation to offer for NHS National Pharmaceuticals Transition 2020_1 Offer reference number: CM/PHG/19/5586 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 42 months. Potential periods of call-offs under the framework agreement: LSNE: 4.5.2020 to 31.1.2022 (21 months); CESW: 4.5.2020 to 31.1.2021 (9 months); NWLN: 4.5.2020 to 31.7.2021 (15 months). Products on the framework include (but are not limited to): Aliskiren Aprepitant Arsenic Atazanavir Atomoxetine Bortezomib Carglumic Clofarabine Darunavir Dexmedetomidine Dexrazoxane Erlotinib Exenatide Irinotecan Ganciclovir Gefitinib Irinotecan Labetalol Melatonin Metaraminol Methylthioninium Miglustat Olopatadine Ritonavir Solifenacin Temsirolimus Thalidomide Tipranavir Trabectedin Ziconotide Details of presentation sizes and volumes are within the tender document set. NHS National Pharmaceuticals Transition 2020_1 Offer reference number: CM/PHG/19/5586 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 42 months. Potential periods of call-offs under the framework agreement: LSNE: 4.5.2020 to 31.1.2022 (21 months); CESW: 4.5.2020 to 31.1.2021 (9 months); NWLN: 04.5.2020 to 31.7.2021 (15 months). NHS National Pharmaceuticals Transition 2020_1 Offer reference number: CM/PHG/19/5586 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 42 months. Potential periods of call-offs under the framework agreement: LSNE: 4.5.2020 to 31.1.2022 (21 months); CESW: 4.5.2020 to 31.1.2021 (9 months); NWLN: 4.5.2020 to 31.7.2021 (15 months). NHS National Pharmaceuticals Transition 2020_1 Offer reference number: CM/PHG/19/5586 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 42 months. Potential periods of call-offs under the framework agreement: LSNE: 4.5.2020 to 31.1.2022 (21 months); CESW: 4.5.2020 to 31.1.2021 (9 months); NWLN: 4.5.2020 to 31.7.2021 (15 months).